Results 21 to 30 of about 22,631 (237)
Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer [PDF]
Archive of Oncology, 2002 BACKGROUND: Influences of CMF (cyclophosphamide, methotrexate,5-fluorouracil) chemotherapy on blood coagulation were investigated in 30 patients receiving adjuvant chemotherapy and in 30 patients receiving chemotherapy for metastatic breast cancer ...
Petrović Dragana
doaj +1 more source
Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates [PDF]
, 2002 Antithrombin (AT) circulates in plasma in two isoforms, AT-alpha (90-95%) and AT-beta (5-10%). AT isoform proportions were measured in plasma samples of 17 healthy subjects and 26 posttraumatic or postoperative septic patients, as well as in 4 ...
Inthorn, D. +6 more
core +1 more source
Hypoprothrombinemia in the compensated form of hepatosplenic schistosomiasis: further studies
Revista do Instituto de Medicina Tropical de São Paulo, 1988 Coagulation abnormality is frequently observed in schistosomiasis patients but its pathophysiology has not been established. We measured, by immunodiffusion.
Nora Manoukian, Durval Rosa Borges
doaj +1 more source
Antithrombin III: Plasma Activity and Reference Range Among Nigerian Blood Donors
Nigerian Postgraduate Medical Journal, 2015 Background: Diagnosis of antithrombin III (ATIII) deficiency as a common cause of thrombophilia is primarily based on the determination of antithrombin levels in plasma using a functional activity assay or an immunological assay, but local reference ...
Vincent Oluseye Osunkalu +2 more
doaj +1 more source
The Level of Antithrombin III (AT III) in Turkish Diabetics
Endocrinology Research and Practice, 2022 A natural anti-coagulant AT III plays a defensive role against intravascular coagulation and regulates blood hemostasis. Diabetes is associated with hypercoagulable state.
Füsun Hamulu +6 more
doaj +2 more sources
COPD, 2022 We aimed to explore the role of antithrombin III (AT-III) activity in diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and chronic bronchitis, and its relationship with all-cause mortality of AECOPD patients ...
Shuling Zhang +6 more
doaj +1 more source
Massive Pulmonary Embolism in a Patient Using Warfarin at Therapeutic Dose [PDF]
Journal of Clinical and Diagnostic Research, 2016 Warfarin sodium is commonly used for the prevention and treatment of thromboembolism. The efficacy of warfarin therapy depends on maintaining the International Normalised Ratio (INR) within the target range for the indication.
Sunnetcioglu Aysel +2 more
doaj +1 more source
Thrombin–antithrombin III complex tests
Journal of Orthopaedic Surgery, 2017 Purpose: Patients with fractures of the pelvis and/or lower extremities are at a high risk of developing postoperative venous thromboembolism (VTE). The purpose of this study was to determine whether the thrombin–antithrombin III complex (TAT) tests ...
Sang Yang Lee +5 more
doaj +1 more source
Antithrombin III Protects Against Contrast-Induced Nephropathy
EBioMedicine, 2017 We previously reported that insufficiency of antithrombin III (ATIII), the major anti-coagulation molecule in vivo, exacerbated renal ischemia-reperfusion injury in animal models and possibly humans. In the present study, we investigated the relationship
Zeyuan Lu +8 more
doaj +1 more source
Tromboembolias múltiplas associadas a défice de anti-trombina III.
Acta Médica Portuguesa, 1991 Congenital deficiency of antithrombin III is considered as one serious primary hypercoagulable state. The authors present a case of deficiency of antithrombin III in a 28 years old young male, with aortic valve disease and several thromboembolic events ...
C Catarino +9 more
doaj +1 more source